Methrotrexate U.S.P. (amethopterin) and methotrexate sodium.
D000028:Abortion, Induced; D000740:Anemia / Q000139:chemically induced; D002051:Burkitt Lymphoma / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury; D002822:Choriocarcinoma / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000139:chemically induced; D013736:Testicular Neoplasms; D013921:Thrombocytopenia / Q000139:chemically induced; D014527:Uric Acid / Q000097:blood; D014594:Uterine Neoplasms / Q000188:drug therapy
D014527:Uric Acid; D008727:Methotrexate